Virology News and Research

Latest Virology News and Research

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for HIV-related Kaposi's Sarcoma

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.

8 Jan 2015

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

H&P Labs Inc. announced an agreement with Harvard University and Brigham and Women's Hospital to license two classes of compounds in order to develop an oral drug therapy against Ebola.

8 Jan 2015

Current flu vaccine still offers protection, says Loyola infectious disease specialist

In baseball, three strikes and you're out. The most common annual vaccine targets three strains of flu virus. This year, two vaccine strains are spot on and successfully matched. One strain is partially mismatched, but still believed to offer partial coverage for that strain. The current flu vaccine is still in the game and, more importantly, keeping people well and on the playing field, says a Loyola University Medical Center infectious disease specialist.

8 Jan 2015

Johns Hopkins-led study offers strategy to eradicate HIV

Luring dormant HIV out of hiding and destroying its last cure-defying holdouts has become the holy grail of HIV eradication, but several recent attempts to do so have failed. Now the findings of a Johns Hopkins-led study reveal why that is and offer a strategy that could form a blueprint for a therapeutic vaccine to eradicate lingering virus from the body.

8 Jan 2015

Using HIV drugs to treat AMD: an interview with Dr Mark Young

NRTIs are compounds which were originally developed in the 1960s as anti-cancer agents. They are similar in structure to the bases which make up DNA, and it was hoped that they would interfere with DNA replication in fast-growing cancer cells, slowing down or stopping tumour growth.

7 Jan 2015

Everyday actions could help prevent spread of flu among college students

As local college students return to Philadelphia from their long winter breaks over the next several days, it is likely that they'll be bringing who-knows-what germs with them from home, said Stacey A. Gorski, PhD, a biology professor who specializes in immunology at University of the Sciences in Philadelphia.

7 Jan 2015

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Johnson & Johnson today announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies.

6 Jan 2015

Geographic information systems provide real-time surveillance of disease outbreaks at mass events

Infectious diseases are one of the many health issues that worry the organizers of mass gatherings, such as the Hajj and the World Cup.

6 Jan 2015

Outbreaks of infectious diseases offer lessons for critical care providers

Outbreaks of infectious diseases, such as Ebola in West Africa, offer insight for how healthcare professionals can respond more effectively to current and future challenges, according to editors of the American Journal of Critical Care.

5 Jan 2015

Researchers use whole genome sequencing to track evolution of chicken flu virus

An international research team has shown how changes in a flu virus that has plagued Chinese poultry farms for decades helped create the novel avian H7N9 influenza A virus that has sickened more than 375 people since 2013. The research appears in the current online early edition of the scientific journal Proceedings of the National Academy of Sciences.

30 Dec 2014

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.

From Roche Sequencing and Life Science 30 Dec 2014

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen R&D Ireland announced today an amendment to its existing agreement with Gilead Sciences, Inc., initially established in 2011, for the development of a once daily, darunavir-based, single-tablet regimen (STR) for the treatment of people living with HIV.

29 Dec 2014

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

Based on its recent analysis of the influenza vaccines market, Frost & Sullivan recognises Protein Sciences with the 2013 Global New Product Innovation Award. Flublok is the world's first recombinant protein vaccine for the prevention of seasonal influenza disease to gain U.S. FDA approval.

29 Dec 2014

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

EB Pharma, LLC., a subsidiary of Eiger BioPharmaceuticals, Inc., announced that it has executed an agreement with Janssen Pharmaceutica NV, for an exclusive license, to tipifarnib in the field of virology and a related, clinical stage back-up compound.

23 Dec 2014

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.

23 Dec 2014

Virology News and Research

Latest Virology News and Research

CytRx reports positive interim results from aldoxorubicin Phase 2 trial for HIV-related Kaposi's Sarcoma

H&P Labs announces licensing agreement to develop oral drug therapy against Ebola

Current flu vaccine still offers protection, says Loyola infectious disease specialist

Johns Hopkins-led study offers strategy to eradicate HIV

Using HIV drugs to treat AMD: an interview with Dr Mark Young

Everyday actions could help prevent spread of flu among college students

Johnson & Johnson begins Phase 1 trial of preventive Ebola vaccine program

Geographic information systems provide real-time surveillance of disease outbreaks at mass events

Outbreaks of infectious diseases offer lessons for critical care providers

Researchers use whole genome sequencing to track evolution of chicken flu virus

FDA provides Emergency Use Authorization for Roche's LightMix Ebola Zaire rRT-PCR Test

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Protein Sciences earns Frost & Sullivan 2013 Global New Product Innovation Award

EB Pharma licenses tipifarnib from Janssen to study potential new therapy for HDV

Abbvie’s HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval

Study underscores the importance of appropriate testing, support and care for HCV patients

Medical researchers at Saint Louis University bring hope to those in pain and sickness

Experimental Ebola vaccine safe and immunogenic in African population

Infectious disease specialist underscores the importance of flu vaccines

Cell-associated HIV transmission contributes to HIV epidemic

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production